Market Research Future Adds The “Cruciate Ligament Diagnosis & treatment Market Report –Forecast Till 2027” Report To Their Unique Collection.
The cruciate ligament treatment includes numerous surgical techniques that involve reconstruction and replacement of the knee and related ligaments. The upsurge in obese population is considered as a chief factor emphasizing the growth of this market. Obesity in the aging population has been reported to directly increase the risk of degenerative bone disorders, such as osteoporosis and osteoarthritis, additionally resulting in target injury and fracture owing to the extra pressure exerted on joints. Later, increasing number of people who have osteoporosis is expected to generate demand for the market.
However, the lack of availability of skilled professionals and the high cost of treatment procedures may hinder the growth of the market during the forecast period.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6080
Many prominent players in the market have incorporated into acquisitions, mergers, and continuous launches of quality systems to hold the market position. The firms are focusing on mergers and acquisitions to enhance their product portfolio. For instance, the acquisition of Cayenne Medical by Zimmer Biomet was involved in reconstruction solutions and advanced soft tissue repair for knee, shoulder, and extremities. Besides, companies are involving into geographic expansions to cater to the untargeted population for tissue repair and surgeries. Regional Analysis The global cruciate ligament diagnosis and treatment market consists of four regions, namely, Americas, Europe, Asia Pacific, and the Middle East and Africa. The American region holds the major share of the global cruciate ligament diagnosis and treatment market, owing to the existing well-established healthcare system, increasing prevalence of degenerative bone disorder cases, and technological advancements. Sports such as soccer, football, and skiing have been reported to be high-risk sports that can cause injury to the ACL when compared to other sports activities. For instance, due to increasing occurrences of ACL injuries, nearly 100,000 ACL reconstructions are performed each year as per a report published by PubMed. Europe holds the second position in the global cruciate ligament diagnosis and treatment market. It is expected that the government support towards research and development expenditure and rising prevalence of chronic bone diseases are likely to drive the European cruciate ligament diagnosis and treatment market. The Asia Pacific cruciate ligament diagnosis and treatment market consist of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia Pacific. Japan is the largest market for cruciate ligament diagnosis and treatment due to an increase in the prevalence of cancer and demand for cruciate ligament diagnosis and treatment techniques. In China, factors responsible for the market growth are rising geriatric population with osteoporosis diseases and availability of low-cost diagnostic and treatment options. The Middle East and Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities. Segmentation The global cruciate ligament diagnosis and treatment market is segmented on the basis of type, injury type, product, diagnosis, treatment, and end-user. Based on type, the global cruciate ligament diagnosis and treatment market is classified as Posterior Cruciate Ligament (PCL) and Anterior Cruciate Ligament (ACL). The segments for injury type for the global cruciate ligament diagnosis and treatment market are classified as grade I, grade II, and grade III. On the basis of product, the global cruciate ligament diagnosis and treatment market is classified as cemented implants, cement-less implants, partial implants, and revision implants. Based on indication, the global cruciate ligament diagnosis and treatment market is classified as osteoarthritis, rheumatoid arthritis, trauma, and others. The diagnosis segment for the global cruciate ligament diagnosis and treatment market is classified as imaging and others. The imaging segment is further classified as abdominal x-ray, Magnetic Resonance Imaging (MRI), ultrasound, laparoscopy, angiography, and others. Based on treatment, the global cruciate ligament diagnosis and treatment market is classified as surgery, therapies, devices, and others. Surgery can be further sub-divided into arthroscopy, Anterior Cruciate Ligament (ACL) reconstruction, and others. The therapies include rehabilitation and physical therapies. The devices include elastic bandages and others. On the basis of end-user, the global cruciate ligament diagnosis and treatment market is classified as hospitals, orthopedic clinics, Ambulatory Surgical Center (ASC), and others. Global Cruciate Ligament Diagnosis & Treatment Key Players Stryker Corporation (U.S.), Arthrex, Inc. (U.S.), Zimmer Biomet (U.S.), DePuy Synthes, Inc. (U.S.), CONMED Corporation (U.S.), Smith & Nephew plc. (U.S.), DJO Global Inc. (U.S.), Breg, Inc. (U.S.), Bauerfeind AG (Germany), Össur hf. (Iceland), DeRoyal Industries, Inc. (U.S.), BSN Medical GmbH (Germany), 3M Company (U.S.), Otto Bock Healthcare GmbH (Germany), THUASNE SA (France), medi GmbH & Co. KG (Germany), DeRoyal Industries Inc. (U.S.), Corin Group (UK), United Orthopedic Corporation (Taiwan), Exactech Inc. (U.S.), Japan Medical Dynamic Marketing (Japan), Tornier Inc. (U.S.), and others are some prominent players in this market. Browse more details of Report @ https://www.marketresearchfuture.com/reports/cruciate-ligament-diagnosis-treatment-6080
Comentarios